NAPLEX Quiz
20 questions · no time limit
0:00
PHARMACY MANAGEMENT AND LEADERSHIP
Question 1 of 20
No time limit
Current
Answered
Flagged
Not seen
A pharmacy-led MUE reviews monitoring for hepatotoxicity in a 61-year-old female (weight 72 kg) treated for latent tuberculosis infection. Medications: isoniazid 300 mg daily plus pyridoxine 25 mg daily (started 6 weeks ago; adherent), and atorvastatin 20 mg nightly; she reports new fatigue and decreased appetite. Labs: AST 145 U/L (10–40), ALT 172 U/L (7–56), total bilirubin 1.8 mg/dL (0.2–1.2), SCr 0.9 mg/dL (0.6–1.2). The goal is safe completion of therapy while preventing severe liver injury. What monitoring parameter is most critical for this patient's therapy?
YOUR PROGRESS
20
QUESTIONS
Ready when you are
Answer in any order. Your progress shows here as you go.
QUESTIONS
KEYBOARD
Pick an answer ABCD
Next question ↵→
Previous ←
Flag for review F
Answers save as you go · flagged questions come back at the end